Zhang Y, Jiang W, Xu C, Tian J, et al. The impact of proactive versus reactive drug monitoring of infliximab on treatment outcomes in patients with crohn's disease. Scand J Gastroenterol 2023 Nov 22:1-11. doi: 10.1080/00365521.2023.2283387.
PMID: 37991266